Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Crohn's disease and skin.

Literature DB >> 27087942

Crohn's disease and skin.

A G Gravina¹, A Federico¹, E Ruocco², A Lo Schiavo², F Romano², A Miranda¹, D Sgambato¹, M Dallio¹, V Ruocco², C Loguercio¹, M Romano¹.

Abstract

Crohn's disease is a chronic inflammatory bowel disease potentially involving any segment of the gastrointestinal tract. Extra-intestinal manifestations may occur in 6%-40% of patients, and disorders of the skin are among the most common. This manuscript will review skin manifestations associated to Crohn's disease, with a particular focus on lesions associated to anti-tumour necrosis factor therapy.

Entities: Disease Species

Keywords: Crohn’s disease; anti-tumour necrosis factor-alpha; dermatologic manifestation; inflammatory bowel disease

Year: 2015 PMID： 27087942 PMCID： PMC4804366 DOI： 10.1177/2050640615597835

Source DB: PubMed Journal: United European Gastroenterol J ISSN： 2050-6406 Impact factor: 4.623

37 in total

Review 1. Extraintestinal manifestations in inflammatory bowel disease.

Authors: Silvio Danese; Stefano Semeraro; Alfredo Papa; Italia Roberto; Franco Scaldaferri; Giuseppe Fedeli; Giovanni Gasbarrini; Antonio Gasbarrini
Journal: World J Gastroenterol Date: 2005-12-14 Impact factor: 5.742

2. Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a 'patchy cutaneous' immune suppression?

Authors: Franco Scaldaferri; Valentina Petito; Alfredo Papa; Monica Cesarini; Vincenzo Arena; Loris Riccardo Lopetuso; Maddalena Corbi; Francesca Perino; Giacomo Caldarola; Angelo Carbone; Enrico Corazziari; Alessandro Sgambato; Antonio Gasbarrini; Clara De Simone
Journal: Gut Date: 2013-11-19 Impact factor: 23.059

3. Strong overexpression of CXCR3 axis components in childhood inflammatory bowel disease.

Authors: Sebastian Schroepf; Roland Kappler; Stephan Brand; Christine Prell; Peter Lohse; Jürgen Glas; Eva Hoster; Johanna Helmbrecht; Antje Ballauff; Michael Berger; Dietrich von Schweinitz; Sibylle Koletzko; Martin Lacher
Journal: Inflamm Bowel Dis Date: 2010-11 Impact factor: 5.325

Review 4. Risk of malignancy including non-melanoma skin cancers with anti-tumor necrosis factor therapy in patients with rheumatoid arthritis: meta-analysis of registries and systematic review of long-term extension studies.

Authors: Pierre Le Blay; Gael Mouterde; Thomas Barnetche; Jacques Morel; Bernard Combe
Journal: Clin Exp Rheumatol Date: 2012-10-17 Impact factor: 4.473

Review 5. Psoriasis and pustular dermatitis triggered by TNF-{alpha} inhibitors in patients with rheumatologic conditions.

Authors: Gillian C de Gannes; Mehran Ghoreishi; Janet Pope; Anthony Russell; David Bell; Stewart Adams; Kamran Shojania; Magdalena Martinka; Jan P Dutz
Journal: Arch Dermatol Date: 2007-02

Review 6. Induction or exacerbation of psoriatic lesions during anti-TNF-α therapy for inflammatory bowel disease: a systematic literature review based on 222 cases.

Authors: Rafael Denadai; Fábio Vieira Teixeira; Flavio Steinwurz; Ricardo Romiti; Rogério Saad-Hossne
Journal: J Crohns Colitis Date: 2012-09-07 Impact factor: 9.071

7. Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases.

Authors: Andreas Wollenberg; Moritz Wagner; Sandra Günther; Andreas Towarowski; Evelyn Tuma; Martina Moderer; Simon Rothenfusser; Stefanie Wetzel; Stefan Endres; Gunther Hartmann
Journal: J Invest Dermatol Date: 2002-11 Impact factor: 8.551

Review 8. Crohn's disease and its mucocutaneous involvement.

Authors: Eleonora Ruocco; Antonio Cuomo; Raffaele Salerno; Vincenzo Ruocco; Marco Romano; Adone Baroni
Journal: Skinmed Date: 2007 Jul-Aug

9. Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment.

Authors: Cornelia Tillack; Laura Maximiliane Ehmann; Matthias Friedrich; Rüdiger P Laubender; Pavol Papay; Harald Vogelsang; Johannes Stallhofer; Florian Beigel; Andrea Bedynek; Martin Wetzke; Harald Maier; Maria Koburger; Johanna Wagner; Jürgen Glas; Julia Diegelmann; Sarah Koglin; Yvonne Dombrowski; Jürgen Schauber; Andreas Wollenberg; Stephan Brand
Journal: Gut Date: 2013-03-06 Impact factor: 23.059

Crohn's disease and skin.

Review 1. Extraintestinal manifestations in inflammatory bowel disease.

2. Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a 'patchy cutaneous' immune suppression?

3. Strong overexpression of CXCR3 axis components in childhood inflammatory bowel disease.

Review 4. Risk of malignancy including non-melanoma skin cancers with anti-tumor necrosis factor therapy in patients with rheumatoid arthritis: meta-analysis of registries and systematic review of long-term extension studies.

Review 5. Psoriasis and pustular dermatitis triggered by TNF-{alpha} inhibitors in patients with rheumatologic conditions.

Review 6. Induction or exacerbation of psoriatic lesions during anti-TNF-α therapy for inflammatory bowel disease: a systematic literature review based on 222 cases.

7. Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases.

Review 8. Crohn's disease and its mucocutaneous involvement.

9. Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment.

10. Skin manifestations of inflammatory bowel disease.

Review 1. The emerging role of neutrophilic extracellular traps in intestinal disease.

2. Skin manifestations associated with systemic diseases - Part II.

Review 3. Leaky Gum: The Revisited Origin of Systemic Diseases.

4. Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study.

Review 5. Computational Biology and Machine Learning Approaches to Understand Mechanistic Microbiome-Host Interactions.